Alignment Healthcare COO receives stock grant

Burzacchi Sebastian reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Burzacchi Sebastian reported acquisition or exercise transactions in this Form 4 filing.

Alignment Healthcare, Inc. reported that COO - Mgmt Services Org Sebastian Burzacchi received a grant of 36,198 shares of Common Stock in the form of restricted stock units. These units carry no purchase price and increase his direct holdings to 273,991 shares after the award.

According to the terms, the 36,198 restricted stock units will vest in three approximately equal installments on each of the first three anniversaries of the grant date, as long as Burzacchi continues to provide service to the company on each vesting date. This is a compensation-related equity award rather than an open‑market share purchase.

Insider Trade Summary

Grant/Award: 36,198 shares

Grant/Award 1 txn

Insider Burzacchi Sebastian

Role COO - Mgmt Services Org

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	36,198	$0.00	$0.00

Holdings After Transaction: Common Stock — 273,991 shares (Direct)

Footnotes (1)

1. F1. Represents 36,198 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Alignment Healthcare (ALHC) report for Sebastian Burzacchi?

Alignment Healthcare reported a compensation-related stock grant to COO Sebastian Burzacchi. He received 36,198 restricted stock units of Common Stock, increasing his direct holdings to 273,991 shares following the grant, with no open-market buying or selling involved.

How many Alignment Healthcare (ALHC) shares did Sebastian Burzacchi receive in this Form 4 filing?

Sebastian Burzacchi received 36,198 restricted stock units of Alignment Healthcare Common Stock. Each unit represents one share, bringing his total direct holdings to 273,991 shares after the grant, according to the reported post-transaction ownership figure in the filing.

Is the Sebastian Burzacchi ALHC Form 4 transaction a stock grant or open-market purchase?

The transaction is a stock grant, not an open-market purchase. The filing shows code “A” for grant or award, a price of $0.0000 per share, and describes 36,198 restricted stock units issued as part of his compensation package.

What are the vesting terms of Sebastian Burzacchi’s Alignment Healthcare restricted stock units?

The 36,198 restricted stock units vest in three installments. Approximately one third will vest on each of the first three anniversaries of the grant date, provided Burzacchi continues serving Alignment Healthcare on each applicable vesting date.

What is Sebastian Burzacchi’s total Alignment Healthcare share ownership after this grant?

After the grant, Sebastian Burzacchi directly holds 273,991 shares of Alignment Healthcare Common Stock. This post-transaction figure in the Form 4 includes the newly awarded 36,198 restricted stock units that were added to his existing direct holdings.

Does the Sebastian Burzacchi Form 4 for Alignment Healthcare involve derivative securities or options?

No derivative securities or options are reported in this Form 4. The transaction involves non-derivative Common Stock through 36,198 restricted stock units, and the derivative summary section in the data provided shows no outstanding derivative positions.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/17/2026 - 05:22 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Burzacchi Sebastian

(Last) (First) (Middle)

1100 W. TOWN & COUNTRY RD.

SUITE 1600

(Street)

ORANGE CA 92868

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Alignment Healthcare, Inc. [ ALHC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	COO - Mgmt Services Org

3. Date of Earliest Transaction (Month/Day/Year)
03/13/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/13/2026		A		36,198(1)	A	$0	273,991	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents 36,198 restricted stock units, each restricted stock unit representing the right to receive one share of Common Stock of the Company, that will vest approximately one third on each of the first three anniversaries of the grant date, subject to the reporting person's continued service to the Company as of the applicable vesting date.

Remarks:

	/s/ Christopher J. Joyce, as Attorney-in-Fact, for Sebastian Burzacchi	03/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.